Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | |
| Cash Flows From Operating Activities | |
| Net Income | 2,450 |
| Depreciation Amortization | 1,820 |
| Other Working Capital | 62,150 |
| Other Operating Activity | -10,980 |
| Operating Cash Flow | $55,440 |
| Cash Flows From Investing Activities | |
| PPE Investments | -410 |
| Net Acquisitions | 670 |
| Other Investing Activity | -2,050 |
| Investing Cash Flow | $-1,790 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 76,940 |
| Financing Cash Flow | $76,940 |
| Exchange Rate Effect | 8,650 |
| Beginning Cash Position | 10,040 |
| End Cash Position | 149,280 |
| Net Cash Flow | $139,240 |
| Free Cash Flow | |
| Operating Cash Flow | 55,440 |
| Free Cash Flow | 55,440 |